Published in PLoS One on January 27, 2011
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer (2013) 4.02
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J (2011) 2.92
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One (2012) 2.77
The gut microbiome modulates colon tumorigenesis. MBio (2013) 2.45
Towards the human colorectal cancer microbiome. PLoS One (2011) 2.30
The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) (2014) 2.08
Fusobacterium is associated with colorectal adenomas. PLoS One (2013) 1.99
Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol (2013) 1.93
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity (2015) 1.92
The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol (2011) 1.86
IL-17 family: cytokines, receptors and signaling. Cytokine (2013) 1.66
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J (2012) 1.62
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One (2013) 1.62
Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48
Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol (2014) 1.44
The intestinal microbiota in health and disease. Curr Opin Gastroenterol (2012) 1.43
Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol (2013) 1.37
The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol (2011) 1.22
Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep (2012) 1.18
Bacterial oncogenesis in the colon. Future Microbiol (2013) 1.18
Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med (2013) 1.17
Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. Cancer Res (2013) 1.16
Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett (2011) 1.12
Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics (2011) 1.08
Gastrointestinal malignancy and the microbiome. Gastroenterology (2014) 1.07
Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One (2014) 1.05
Microbiota disbiosis is associated with colorectal cancer. Front Microbiol (2015) 1.02
Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm Bowel Dis (2016) 1.02
Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci (2013) 1.02
Colorectal cancer: looking for answers in the microbiota. Cancer Discov (2013) 1.02
Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. Cell Host Microbe (2015) 1.01
Potential role of probiotics on colorectal cancer prevention. BMC Surg (2012) 1.01
Diversified pattern of the human colorectal cancer microbiome. Gut Pathog (2013) 1.01
Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res (2013) 1.00
Interleukin-17: a promoter in colorectal cancer progression. Clin Dev Immunol (2013) 1.00
Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas. BMC Cancer (2013) 1.00
Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. MBio (2015) 1.00
Gut microbiota imbalance and colorectal cancer. World J Gastroenterol (2016) 0.99
Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett (2014) 0.98
The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes (2013) 0.98
Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96
The human gut virome: a multifaceted majority. Front Microbiol (2015) 0.95
The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol (2014) 0.94
Beneficial and Detrimental Roles of NLRs in Carcinogenesis. Front Immunol (2013) 0.94
Gut microbiome and colorectal adenomas. Cancer J (2014) 0.94
Cancer in inflammatory bowel disease: lessons from animal models. Curr Opin Gastroenterol (2012) 0.93
Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect Dis (2013) 0.92
Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ (2014) 0.90
Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res (2013) 0.90
Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes (2013) 0.89
Probiotics, nuclear receptor signaling, and anti-inflammatory pathways. Gastroenterol Res Pract (2011) 0.88
Intestinal iron homeostasis and colon tumorigenesis. Nutrients (2013) 0.88
Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep (2014) 0.88
Sex, body mass index, and dietary fiber intake influence the human gut microbiome. PLoS One (2015) 0.88
Recurrent antibiotic exposure may promote cancer formation - Another step in understanding the role of the human microbiota? Eur J Cancer (2015) 0.88
Microbiota separation and C-reactive protein elevation in treatment-naïve pediatric granulomatous Crohn disease. J Pediatr Gastroenterol Nutr (2012) 0.88
Relationship between intestinal microbiota and colorectal cancer. World J Gastrointest Oncol (2015) 0.88
Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) (2016) 0.88
Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget (2015) 0.88
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep (2013) 0.87
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. EBioMedicine (2016) 0.87
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med (2015) 0.87
Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol (2014) 0.86
Fusobacterium spp. and colorectal cancer: cause or consequence? Trends Microbiol (2013) 0.86
Mechanisms and therapeutic effectiveness of lactobacilli. J Clin Pathol (2015) 0.85
Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes (2012) 0.84
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. World J Gastroenterol (2014) 0.84
Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes (2015) 0.83
Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients (2014) 0.83
The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. Toxins (Basel) (2013) 0.83
Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups. World J Gastroenterol (2015) 0.83
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therap Adv Gastroenterol (2013) 0.83
Co-occurrence of driver and passenger bacteria in human colorectal cancer. Gut Pathog (2014) 0.83
Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer (2015) 0.82
Gut Microbiota Modification: Another Piece in the Puzzle of the Benefits of Physical Exercise in Health? Front Physiol (2016) 0.82
Modification in the diet can induce beneficial effects against breast cancer. World J Clin Oncol (2014) 0.82
Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep (2016) 0.81
Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol (2014) 0.81
A physicians' wish list for the clinical application of intestinal metagenomics. PLoS Med (2014) 0.81
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget (2015) 0.80
The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening. PLoS One (2014) 0.80
Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome. Am J Physiol Gastrointest Liver Physiol (2014) 0.80
Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma. Appl Environ Microbiol (2014) 0.80
Microbial activation of gut dendritic cells and the control of mucosal immunity. J Interferon Cytokine Res (2013) 0.80
The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer (2015) 0.80
The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep (2013) 0.79
Gut microbiota, inflammation and colorectal cancer. Genes Dis (2016) 0.79
Helicobacter pylori infection and colorectal carcinoma: is there a causal association? J Gastrointest Oncol (2012) 0.79
Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice. PLoS One (2015) 0.79
Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab Invest (2014) 0.79
Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases. PLoS One (2016) 0.79
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J (2017) 0.78
Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study. Dig Dis Sci (2015) 0.78
The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome. Cold Spring Harb Perspect Med (2015) 0.78
An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis. Oncogenesis (2016) 0.78
Mucosa-Associated Faecalibacterium prausnitzii Phylotype Richness Is Reduced in Patients with Inflammatory Bowel Disease. Appl Environ Microbiol (2015) 0.78
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol (2007) 60.97
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98
The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res (2005) 24.85
Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol (2007) 23.64
Evolution of mammals and their gut microbes. Science (2008) 21.40
Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol (1977) 17.41
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol (1990) 11.14
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08
Plasticity of CD4+ T cell lineage differentiation. Immunity (2009) 8.08
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45
Towards the human intestinal microbiota phylogenetic core. Environ Microbiol (2009) 5.72
Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol (2010) 5.57
Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut (2003) 5.19
From dissimilarities among species to dissimilarities among communities: a double principal coordinate analysis. J Theor Biol (2004) 4.61
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut (2008) 4.10
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
Obesity and the human microbiome. Curr Opin Gastroenterol (2010) 3.38
Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol (2004) 3.03
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut (2007) 2.32
Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin Infect Dis (2008) 2.29
Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis (2001) 1.96
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. Cancer Res (1997) 1.67
Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol (2004) 1.66
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol (2009) 1.64
Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans. Gut (2009) 1.62
More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS One (2009) 1.09
Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res (2008) 0.94
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Power and limitations of the chloroplast trnL (UAA) intron for plant DNA barcoding. Nucleic Acids Res (2006) 5.31
Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med (2006) 4.36
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes (2010) 3.39
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology (2002) 2.56
Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr (2013) 2.52
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflamm Bowel Dis (2014) 2.46
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology (2005) 2.33
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut (2012) 2.17
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology (2007) 1.94
Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol (2009) 1.89
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86
Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum (2011) 1.82
Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med (2012) 1.73
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. Blood (2011) 1.71
Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg (2013) 1.68
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res (2010) 1.64
Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol (2006) 1.61
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics (2009) 1.58
Relationship between ventilatory settings and barotrauma in the acute respiratory distress syndrome. Intensive Care Med (2002) 1.57
Revision total hip arthroplasty performed after fracture of a ceramic femoral head. A multicenter survivorship study. J Bone Joint Surg Am (2003) 1.52
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily. J Hepatol (2007) 1.49
Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res (2003) 1.48
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact (2005) 1.45
A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol (2005) 1.43
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma. Liver Int (2009) 1.40
Impact of lactobacilli on orally acquired listeriosis. Proc Natl Acad Sci U S A (2012) 1.38
Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol (2002) 1.33
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl (2005) 1.28
Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med (2008) 1.28
Should yoghurt cultures be considered probiotic? Br J Nutr (2005) 1.27
Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems. Protein Expr Purif (2011) 1.26
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol (2011) 1.25
Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact (2007) 1.25
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol (2006) 1.25
Estimation of pig fecal contamination in a river catchment by real-time PCR using two pig-specific Bacteroidales 16S rRNA genetic markers. Appl Environ Microbiol (2009) 1.22
Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-κB modulation in the human gut. PLoS One (2010) 1.22
Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun (2003) 1.21
Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology (2004) 1.21
Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol Lett (2005) 1.20
Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol (2009) 1.19
Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol (2011) 1.17
Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg (2007) 1.16
Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan. J Biol Chem (2011) 1.15
Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion (2006) 1.14
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact (2013) 1.14
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes (2010) 1.13
Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect (2005) 1.13
An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol (2004) 1.13
Patterns of mortality in sickle cell disease in adults in France and England. Hematol J (2002) 1.12
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France. J Med Virol (2010) 1.11
Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant (2005) 1.11
Thiostrepton tryptophan methyltransferase expands the chemistry of radical SAM enzymes. Nat Chem Biol (2012) 1.10
The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med (2003) 1.09
Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii. Inflamm Bowel Dis (2014) 1.08
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation. Sci Transl Med (2010) 1.08
Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie (2010) 1.08
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study. Br J Haematol (2014) 1.05
Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microbiol (2006) 1.05
Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine (2007) 1.04
Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica (2012) 1.03
Oxidative stress in Lactococcus lactis. Genet Mol Res (2003) 1.03
Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence. Mol Microbiol (2013) 1.03
Computer-assisted analysis helps detect inner dynein arm abnormalities. Am J Respir Crit Care Med (2002) 1.02
Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol (2010) 1.01
Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol Lett (2003) 1.01
Microbiota matures colonic epithelium through a coordinated induction of cell cycle-related proteins in gnotobiotic rat. Am J Physiol Gastrointest Liver Physiol (2010) 1.01
Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis (2011) 1.00
Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study. Transplantation (2004) 1.00
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia. Haematologica (2013) 1.00
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore) (2009) 0.99
Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr (2014) 0.99
A new plasmid vector for DNA delivery using lactococci. Genet Vaccines Ther (2009) 0.99
Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett (2003) 0.99
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation (2004) 0.98
Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol (2002) 0.98
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol (2006) 0.98
Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol (2007) 0.97
Engineering lactococci and lactobacilli for human health. Curr Opin Microbiol (2013) 0.96